Whittier Trust Co. of Nevada Inc. Boosts Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Whittier Trust Co. of Nevada Inc. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.3% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 72,236 shares of the company’s stock after buying an additional 2,280 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in GE HealthCare Technologies were worth $5,628,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Capital Research Global Investors lifted its stake in GE HealthCare Technologies by 5.2% in the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after buying an additional 2,647,204 shares in the last quarter. Vanguard Group Inc. raised its holdings in GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after acquiring an additional 4,107,746 shares during the last quarter. Hotchkis & Wiley Capital Management LLC raised its holdings in GE HealthCare Technologies by 9.4% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock valued at $426,186,000 after acquiring an additional 471,910 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in GE HealthCare Technologies by 17.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,454,690 shares of the company’s stock valued at $267,121,000 after acquiring an additional 504,287 shares during the last quarter. Finally, Norges Bank acquired a new position in GE HealthCare Technologies in the 4th quarter valued at $229,052,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 1.1 %

GE HealthCare Technologies stock traded up $0.95 during trading on Thursday, reaching $84.88. 448,064 shares of the company’s stock were exchanged, compared to its average volume of 2,969,137. The company’s 50-day moving average is $81.14 and its two-hundred day moving average is $83.46. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm has a market cap of $38.74 billion, a price-to-earnings ratio of 24.81, a PEG ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the prior year, the company earned $0.92 EPS. The firm’s revenue was up .5% on a year-over-year basis. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a $0.03 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s payout ratio is currently 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have weighed in on GEHC shares. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Stifel Nicolaus initiated coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target for the company. Bank of America dropped their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. The Goldman Sachs Group initiated coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Finally, Mizuho dropped their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Five investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.